Raffles Medical Group Ltd (SGX:BSL)
Singapore · Delayed Price · Currency is SGD 0.8800
-0.0050 (-0.56%)
Aug 6, 2026, 10:10 AM SGT
Raffles Medical Group Ratios and Metrics
Market cap in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,629 | 1,877 | 1,579 | 2,006 | 2,595 | 2,560 | |
Market Cap Growth | -11.41% | 18.84% | -21.25% | -22.73% | 1.40% | 37.98% |
Enterprise Value | 1,398 | 1,647 | 1,387 | 1,814 | 2,498 | 2,571 |
Last Close Price | 0.89 | 0.99 | 0.80 | 1.00 | 1.26 | 1.20 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 24.24 | 26.60 | 25.38 | 22.25 | 18.12 | 30.41 |
Forward PE | 26.11 | 25.69 | 21.36 | 21.39 | 24.52 | 45.67 |
PS Ratio | 2.20 | 2.45 | 2.10 | 2.83 | 3.15 | 3.53 |
PB Ratio | 1.57 | 1.78 | 1.48 | 1.92 | 2.53 | 2.62 |
P/TBV Ratio | 1.58 | 1.80 | 1.53 | 1.99 | 2.62 | 2.76 |
P/FCF Ratio | 16.09 | 20.08 | 23.58 | 11.88 | 15.16 | 23.23 |
P/OCF Ratio | 14.90 | 18.52 | 18.31 | 10.59 | 13.23 | 15.99 |
PEG Ratio | 87.02 | 2.45 | 2.29 | 2.29 | 2.23 | 1.63 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.89 | 2.15 | 1.84 | 2.56 | 3.03 | 3.55 |
EV/EBITDA Ratio | 11.30 | 14.11 | 12.05 | 13.65 | 10.42 | 17.94 |
EV/EBIT Ratio | 16.95 | 19.16 | 16.30 | 16.76 | 11.72 | 21.75 |
EV/FCF Ratio | 13.81 | 17.62 | 20.71 | 10.75 | 14.59 | 23.34 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.03 | 0.08 | 0.08 | 0.12 | 0.13 | 0.24 |
Debt / EBITDA Ratio | 0.28 | 0.68 | 0.70 | 0.86 | 0.51 | 1.51 |
Debt / FCF Ratio | 0.34 | 0.94 | 1.32 | 0.74 | 0.75 | 2.13 |
Net Debt / Equity Ratio | -0.22 | -0.21 | -0.24 | -0.21 | -0.12 | -0.03 |
Net Debt / EBITDA Ratio | -2.03 | -1.91 | -2.22 | -1.65 | -0.52 | -0.21 |
Net Debt / FCF Ratio | -2.25 | -2.39 | -3.81 | -1.30 | -0.72 | -0.28 |
Asset Turnover | 0.52 | 0.52 | 0.50 | 0.46 | 0.54 | 0.49 |
Inventory Turnover | 37.53 | 37.98 | 35.60 | 30.68 | 32.10 | 37.93 |
Quick Ratio | 1.26 | 1.27 | 1.36 | 1.25 | 1.33 | 1.02 |
Current Ratio | 1.30 | 1.31 | 1.39 | 1.28 | 1.36 | 1.05 |
Return on Equity (ROE) | 6.54% | 6.70% | 5.91% | 8.79% | 14.31% | 8.85% |
Return on Assets (ROA) | 3.59% | 3.68% | 3.52% | 4.42% | 8.66% | 5.01% |
Return on Invested Capital (ROIC) | 7.76% | 7.95% | 7.46% | 9.54% | 17.28% | 9.06% |
Return on Capital Employed (ROCE) | 7.70% | 7.80% | 7.40% | 9.40% | 18.20% | 10.50% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.14% | 3.76% | 3.94% | 4.50% | 5.52% | 3.29% |
FCF Yield | 6.22% | 4.98% | 4.24% | 8.42% | 6.60% | 4.30% |
Dividend Yield | 3.39% | 3.03% | 3.11% | 2.40% | 3.02% | 1.49% |
Payout Ratio | 81.81% | 65.57% | 71.62% | 78.41% | 36.32% | 44.37% |
Buyback Yield / Dilution | 0.45% | 0.36% | 0.41% | -0.12% | 0.54% | -1.96% |
Total Shareholder Return | 3.84% | 3.40% | 3.52% | 2.29% | 3.56% | -0.47% |